What is the typical lead time for production?

The average lead time is within 15 working days for both peak and off-peak seasons.

Are there any safety concerns regarding heavy metals?

No, heavy metals like Lead, Mercury, Cadmium, and Arsenic are all within safe limits.

Sost Supply Mongolin Powder Good Pirce

Name: Sost Supply Mongolin Powder Good Pirce
Brand: Xi an Sost Biotech Co., Ltd.
SKU: 2030273585

Shaanxi, ChinaXi an Sost Biotech Co., Ltd.

US$2,000.00-2,100.00

1 kg

Sample price:US$2100.00/kg.Request sample

Product profile

Customization

Available

CAS No.

480-36-4

Formula

592.55

EINECS

207-547-6

Storage Method

Normal

Shelf Life

>12 Months

Nutrient Composition

Mineral

Resource

Chemosynthesis

The content of active substances

＞90%

Transport Package

1.1 Kilogram Per Aluminum Foil Bag with One Plast

Specification

50%

Trademark

SOST

Origin

China

Production Capacity

100 Kg/Momth

Key features

High Purity Content: Active substance content exceeds 90% with verified HPLC results.

Anti-Aging Benefits: Provides anti-aging, anti-hypoxia, and anti-fatigue effects.

Skin Repair Function: Ecdysone repairs UV-induced DNA damage and maintains moisture.

Strict Safety Standards: Heavy metals and microorganisms meet strict safety limits.

Long Shelf Life: Product remains stable for over 12 months when stored properly.

OEM and ODM Services: Customization services available for manufacturing and packaging.

Fast Lead Time: Average production lead time within 15 working days.

Multiple Payment Options: Supports LC, T/T, D/P, PayPal, and Western Union payments.

Company profile

Xi an Sost Biotech Co., Ltd.

Shaanxi, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2012-11-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.74h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXi'an Sost Biotech Co., Ltd. is identified as a China-based manufacturer and trading company focused on herbal extracts, Chinese medicine raw materials, cosmetic ingredients, healthcare ingredients, food additives, and dietary supplement ingredients. Evidence indicates established production, R&D, sales, purchasing, and quality-control functions, with stated GMP-oriented operations, ISO 9001:2015 certification, multiple production bases, and broad export coverage. However, the records contain conflicting production information: one slice reports three production bases and eight lines, while another reports a 2,990 m² plant and two production lines. The supplier states that it provides pre- and after-sales service and accepts several trade and payment terms, but detailed service performance, customization results, customer references, and financial strength are not sufficiently documented. Monetary figures are omitted.

Supplier typeThe supplier is explicitly classified as a manufacturer and limited company, while another record identifies its business nature as a trading company. Its stated activities include R&D, production, sales, and service of herbal extracts and natural raw materials, so it appears to combine manufacturing and trading functions.

CertificationsThe supplier reports ISO 9001:2015 certification and states that production follows national GMP standards, with GMP-standard factories and 100,000-level clean workshops. ISO certification is explicit; the GMP statements are operational claims rather than a separately named certificate.

After-Sales capabilityThe company explicitly emphasizes before-sales and after-sales service, states that it continuously improves service, and describes service as part of its business operations. However, no evidence gives measurable after-sales performance, service staffing, response times, or documented customer outcomes.

R&D capabilityThe supplier reports an R&D department, research and development of high-purity natural products, biological engineering and natural extraction technology, and an innovation-oriented approach. Nevertheless, only two years of R&D engineer experience are reported, and there is no evidence of patents, new-product records, or quantified R&D achievements.

Production capacityProduction capability is supported by a stated manufacturing plant, natural-extract production activities, GMP-oriented facilities, clean workshops, and product lines covering food, healthcare, cosmetics, and pharmaceutical intermediates. The data are inconsistent: one record states three production bases and eight lines, while another reports a 2,990 m² plant and two lines; quality-control staffing is also reported as fewer than five employees.